The Texas Rangers are facing a dilemma: how to fill the void at second base without looking outside the organization? A challenging task, but one that could shape the team's future.
The recent trade of Marcus Semien for Brandon Nimmo has left a hole in the Rangers' lineup, but they're determined to find a solution internally. This decision might surprise some fans, especially with the team's payroll reduction goal in mind. But here's the twist: it's a strategic move to give their own talent a chance to shine.
Enter Josh Smith, a 28-year-old utility player who's been making his mark across the diamond. With Semien's departure, Smith is poised to step up at second base, particularly against right-handed pitching. His stats are impressive: a .254/.336/.380 slash line over the past two seasons, with 23 homers and 53 doubles. But here's where it gets interesting: Smith has actually played less at second base than other positions in the MLB.
The reason? Semien's incredible durability. He barely missed a game in his first three seasons with the Rangers, leaving little room for others at second base. But with Semien gone, the position is up for grabs. Other players like Cody Freeman, Dylan Moore, and Ezequiel Duran have filled in at second base, but none have matched Smith's major league hitting prowess.
The Rangers have other options, like former first-round pick Justin Foscue, but his major league numbers are underwhelming. Duran and Freeman, despite showing promise, haven't consistently delivered at the plate. And this is the part most people miss: the Rangers' most exciting prospect, Sebastian Walcott, is still a few years away from making an impact.
Walcott, a highly-rated 19-year-old shortstop, could be the future of the team. But for now, the Rangers seem content to fill the second base role internally. They're not looking for big-name free agents or trades, but they might add depth with minor league deals or late offseason bargains. And that's a strategy that could pay off, or could it?
Meanwhile, in other Rangers news, there's a strong desire to re-sign reliever Josh Sborz, who missed the 2025 season due to shoulder surgery. Sborz had an up-and-down 2023, but he was a standout in the playoffs. The Rangers want him back, but on a minor league deal. This decision could be a gamble, as Sborz's health and performance are uncertain. Will he reclaim his spot on the roster? Only time will tell.
What do you think about the Rangers' strategy? Is it a wise move to fill the second base position internally, or should they be more aggressive in the free agent market? Share your thoughts and let's spark a baseball debate!
